-
Targeting inflammation to fight cancer is a new approach with a long history.
CancerDiseasesScientific Research -
Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.
Access to HealthcareDiseasesEthical BusinessSocial Commitment -
Combination of two compounds shows promise in the lab
Access to HealthcareBiomedical ResearchCancerChronic IllnessDiseases -
A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.
DiseasesScientific ResearchScientific Discoveries -
Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
Biomedical ResearchDigitalDiseasesDrug DiscoveryEmerging TechnologyNovartis Institutes for BioMedical Research -
Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
Chronic IllnessDiseasesScientific ResearchScientific Discoveries -
Novartis-Harvard team identifies a new type of cell that is key to the disease.
DiseasesDrug DiscoveryNovartis Institutes for BioMedical ResearchScientific ResearchGenetic Disease -
Read how one caregiver established an association to provide resources for both COPD patients and caregivers.
Chronic IllnessDiseasesRespiratory -
Discover how COPD assessment and treatment are changing.
Chronic IllnessDiseasesLiving With DiseaseRespiratory -
Did you know migraine is the most common of all neurological disorders? Learn more surprising facts.
DiseasesNeuroscience -
Cynthia lives with Heart Failure with preserved Ejection Fraction, a complex and challenging condition.
Disease AwarenessDiseasesHeart FailureMedical InnovationsDrug Development -
Chronic IllnessDiseasesLiving With Disease
Pagination
- 1
- 2
- 3
- › Next page